#54033
Re: Farmas USA
Análisis técnico de los "amigos" de The Street:
AMRN
Se está hablando de:
#54034
Re: Farmas USA
Bien puestas las comillas, jajaja.
AMRN
#54035
Re: Farmas USA
offtopic tema petroleo
La cosa esta para entrar en PXD, es de las que sigo desde hace mas de un año. De por si es ciclica y para comprar en estas fechas, quizas un poco mas adelante. Pero con la situacion actual los tiempos se han acelerado, es un empreson que se recuperara y volvera a los 200 sino mas.
y un poco de literatura,
#54036
Re: Farmas USA
El crudo lo dejare para cuando salga airoso del gas, si es que lo consigo. Acabo de largar oxgn y cbli con pérdidas y no he llegado a tiempo con MY y con snta. Creo que esto va para abajo. Vaya bajonazo de snta :-(
#54037
Re: Farmas USA
Pues que empiece el apocalipsis ya , que cuanto antes empiece antes termina.
#54038
Re: Farmas USA
DVAX
MLV Reiterates Buy On Dynavax Technologies As It Regains Rights To DV1179
Mucho reiterates buy, pero PT de 50$ a 25$. Así nos fue ayer...
#54039
Re: Farmas USA
Stockholders Meeting- December 4, 8:00am - Carlsbad, CA
International Stem Cell Corporation will hold a special meeting of stockholders on December 4, 2014 at 8 AM at the Company’s headquarters in Carlsbad CA. One particular proposal, to authorize a reverse stock split, has resulted in a few inquiries from our supporters and followers.
This proposal is to give ISCO's Board of Directors the authority to decide on a reverse split of the stock at a future date not later than September 30, 2015.
If the proposal passes, the Company has ten months to implement the reverse split, with no date or reverse split ratio yet set. The future date and ratio will be decided by the Board of Directors based on many factors including market conditions, the achievement of milestones and the performance of the stock.
The Company's CEO explained the reasons for the split in his November 2013 letter. The important thing to realize is that the reverse split is not occurring on December 4, 2014. The Company has until the authorization expires on September 30, 2015 for the reverse split after which new stockholders approval will be required.
The proxy information can be found here.
Sincerely,
International Stem Cell Corporation.
#54040
Re: Farmas USA
En principio, la noticia ya tiene que estar descontada, ya que en la carta de noviembre, la empresa ya adelantaba de la necesidad de implementar un R/S para conseguir unprecio de 3$ o aún mejor de 5$....
Por lo tanto, esta noticia no debería influir en el devenir del precio....
Veamos si empezamos a subir ante la expectativa del próximo 18 de diciembre, con el fallo del Tribunal Europeo...
ISCO
"To ensure the Company’s achievements are optimally recognized by the investment community, it’s important that we increase our visibility and position our stock to be more accessible to institutional investors and brokerage firms, which should also help make potential future financings more accretive. The first move is to transition our stock listing to a national securities exchange such as NASDAQ. A national exchange listing and the associated higher stock price should generate greater interest among investors and analysts. If we are successful in generating this interest, I anticipate that the Company’s common stock would have greater liquidity and a stronger long-term investor base.
However, to qualify for listing on a national exchange the stock price needs to be over $3 and ideally closer to $5, which is why the ratio of the reverse split we are proposing at the December 4 stockholders meeting is between 50 and 150. Waiting for the share price to grow organically simply delays our ability to grow the business and bring these important treatments to patients."